A nurse is assessing a client who received magnesium sulfate to treat preterm labor. Which of the following clinical findings should the nurse identify as an indication of toxicity of magnesium sulfate therapy and report to the provider?

Explanation:

A. "This will occur between the fourth and fifth months of pregnancy."

This response is accurate and aligns with the typical timeframe for quickening, which is the first perception of fetal movements by the pregnant person. Quickening commonly occurs between the 16th and 20th week of pregnancy, corresponding to the fourth and fifth months. However, it's essential to note that the exact timing can vary from person to person and pregnancy to pregnancy.

B. "This will happen by the end of the first trimester of pregnancy."

This response is not entirely accurate. Quickening typically occurs later than the end of the first trimester. While some women, particularly those who have been pregnant before, may feel fetal movements toward the end of the first trimester, it's more common to experience quickening during the second trimester.

C. "This will happen once the uterus begins to rise out of the pelvis."

This response is not directly related to quickening. The rising of the uterus (fundus) out of the pelvic cavity is a physical change that occurs as the pregnancy progresses, but it doesn't signify the onset of fetal movements (quickening). Quickening is specifically about feeling the baby's movements, not the position of the uterus.

D. “This will occur during the last trimester of pregnancy."

This response is incorrect. Quickening typically occurs much earlier, specifically during the second trimester, around the 16th to 20th week of pregnancy. Waiting until the last trimester to feel fetal movements would be unusual and might prompt further evaluation or discussion with a healthcare provider.

Explanation:

A. The biparietal diameter

The biparietal diameter is a measurement of the fetal head's diameter, which is often assessed during routine prenatal ultrasounds to estimate gestational age and monitor fetal growth. However, in the scenario described, the client is experiencing heavy vaginal bleeding without contractions at 38 weeks of gestation. The focus is on the immediate concern of the fetus's well-being rather than assessing specific fetal measurements like the biparietal diameter.

B. Viability of the fetus

This choice is correct for the scenario described. Viability refers to the ability of the fetus to survive outside the uterus. Heavy vaginal bleeding near term raises concerns about potential harm to the fetus and its viability. An ultrasound would be performed to assess the fetal heart rate, movement, and overall condition to determine if the fetus is viable or if there are any immediate concerns that need to be addressed.

C. Fetal lung maturity

Fetal lung maturity is typically assessed closer to the end of pregnancy, usually around 36 to 39 weeks of gestation, to determine if the fetus's lungs are developed enough for birth. While important for planning deliveries, assessing fetal lung maturity is not the primary concern in a situation where the client is experiencing heavy vaginal bleeding without contractions at 38 weeks of gestation.

D. Location of the placenta

The location of the placenta is important for monitoring placental health and assessing potential complications such as placenta previa. However, in the context of heavy vaginal bleeding without contractions at 38 weeks of gestation, the immediate concern is the well-being and viability of the fetus rather than the placental location.